ALNY
Price
$257.39
Change
+$2.54 (+1.00%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
32.98B
2 days until earnings call
RARE
Price
$38.05
Change
+$0.07 (+0.18%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
3.57B
2 days until earnings call
Ad is loading...

ALNY vs RARE

Header iconALNY vs RARE Comparison
Open Charts ALNY vs RAREBanner chart's image
Alnylam Pharmaceuticals
Price$257.39
Change+$2.54 (+1.00%)
Volume$14.44K
Capitalization32.98B
Ultragenyx Pharmaceutical
Price$38.05
Change+$0.07 (+0.18%)
Volume$19.76K
Capitalization3.57B
ALNY vs RARE Comparison Chart
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. RARE commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Buy and RARE is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (ALNY: $254.85 vs. RARE: $37.98)
Brand notoriety: ALNY and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 52% vs. RARE: 63%
Market capitalization -- ALNY: $32.98B vs. RARE: $3.57B
ALNY [@Biotechnology] is valued at $32.98B. RARE’s [@Biotechnology] market capitalization is $3.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, ALNY is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while RARE’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 6 bearish.
  • RARE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RARE is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а +9.50% price change this week, while RARE (@Biotechnology) price change was +7.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was -2.03%, and the average quarterly price growth was -10.94%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 31, 2025.

RARE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($33B) has a higher market cap than RARE($3.57B). ALNY YTD gains are higher at: 8.304 vs. RARE (-9.722). ALNY has higher annual earnings (EBITDA): -178.85M vs. RARE (-469M). ALNY has more cash in the bank: 2.7B vs. RARE (610M). RARE has less debt than ALNY: RARE (40.3M) vs ALNY (1.3B). ALNY has higher revenues than RARE: ALNY (2.25B) vs RARE (560M).
ALNYRAREALNY / RARE
Capitalization33B3.57B925%
EBITDA-178.85M-469M38%
Gain YTD8.304-9.722-85%
P/E RatioN/AN/A-
Revenue2.25B560M401%
Total Cash2.7B610M442%
Total Debt1.3B40.3M3,216%
FUNDAMENTALS RATINGS
ALNY vs RARE: Fundamental Ratings
ALNY
RARE
OUTLOOK RATING
1..100
1920
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
25100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5062
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RARE's Valuation (73) in the Biotechnology industry is in the same range as ALNY (99). This means that RARE’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (25) in the Biotechnology industry is significantly better than the same rating for RARE (100). This means that ALNY’s stock grew significantly faster than RARE’s over the last 12 months.

ALNY's SMR Rating (100) in the Biotechnology industry is in the same range as RARE (100). This means that ALNY’s stock grew similarly to RARE’s over the last 12 months.

ALNY's Price Growth Rating (50) in the Biotechnology industry is in the same range as RARE (62). This means that ALNY’s stock grew similarly to RARE’s over the last 12 months.

ALNY's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RARE (100). This means that ALNY’s stock grew similarly to RARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYRARE
RSI
ODDS (%)
Bearish Trend 5 days ago
74%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
67%
Bearish Trend 22 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+1.31%
IONS - ALNY
55%
Loosely correlated
+0.13%
ARGX - ALNY
45%
Loosely correlated
+1.01%
RARE - ALNY
39%
Loosely correlated
-0.29%
ARWR - ALNY
36%
Loosely correlated
+2.04%
REGN - ALNY
35%
Loosely correlated
+1.36%
More

RARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been loosely correlated with ARWR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RARE jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
-0.29%
ARWR - RARE
48%
Loosely correlated
+2.04%
CRNX - RARE
47%
Loosely correlated
+2.22%
DNLI - RARE
47%
Loosely correlated
+3.64%
IONS - RARE
47%
Loosely correlated
+0.13%
RVMD - RARE
46%
Loosely correlated
+6.96%
More